This is a single-center cohort study aimed to describe the urinary excretion kinetics of gadolinium contrast agents (Gd-CAs). Patients with a prescription for injected MRI are invited to participate in the study. If they agree, blood and urine samples are collected before Gd-CAs injection, and urine samples are collected between 0- and two-and-a-half-hours post-injection of Gd-CAs.
over 18 years of age
with a prescription for MRI with gadolinium-based contrast agents (Gd-CAs) injection validated by a radiologist
affiliated with a health insurance plan
have signed an informed consent form
with known allergy to gadolinium-based contrast agents (Gd-CAs)
with known severe renal impairment (GFR < 30 mL/min)
on dialysis
with urinary incontinence
Centre Hospitalier Régional Metz-Thionville
Lead sponsor
University of Lorraine
Collaborator